Cerebrolysin

Cerebrolysin for the treatment of the nervous system, Alzheimer's disease, dementia, ischemic stroke, improvement

Cerebrolysin nootropics

For the treatment of the nervous system, Alzheimer's disease, dementia, ischemic stroke, improvement
Purpose: nervous system, nootropics
Appointment: Alzheimer's disease, dementia, ischemic stroke, improved blood supply to the brain
Indications for use: Chronic heart failure (II-IV functional class according to NYHA classification) in patients receiving standard therapy, including diuretics, digitalis preparations, as well as ACE inhibitors or beta-blockers (not simultaneously).
Contraindications:
- acute renal failure;
- epileptic status;
- hypersensitivity to the medicine.
Composition:
Active substance: complex of peptides obtained from the pig brain-215.2 mg
Excipients: sodium hydroxide, water
Manufacturer: Ever Neuro Pharma